课题基金 / 基金详情

项目摘要

项目成果

Yukikazu Iwasa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Medical imaging is critical for quality health care for early detection and efficient treatment of disease and injury. In 1970s, when MRI became a clinic tool, it was enthusiastically embraced by the hospitals. These hospitals, having since moved from systems of 0.5 T to 1-1.5 T, now target 3 T. However, ~20,000 MRI units now in service worldwide benefit only ~10 % of the total humanity, chiefly in the urban areas of the developed nations. One direct and quick way to redress this glaring disparity and unfairness in medical treatment opportunities is to develop low-cost and easy-to- operate MRI systems. For a vast majority of humanity, low-cost 0.5-T superconducting MRI units would be beneficial and should also help to reduce health care costs in the U.S. Compared with the critical temperatures ( Tc ) of NbTi (~10 K) and Nb 3Sn (~18 K), Tc ~40 K of MgB2 promises obvious advantages. Owing to a higher Tc, an MgB 2 magnet will have its stability considerably enhanced and cryogenic system substantially simplified. Based on the technologies developed in the original project, we propose to complete, at the conclusion of Phase II, a whole- body fully functional MRI magnet of 0.5 T. In this Phase I project, we will address issues, which were not investigated in the original project. In Phase I, our focus will be on the fabrication of MAIN COIL that will be operated in persistent mode. We will address the issues of conductor (particularly performance consistency in long lengths), protection, and temporal stability. In Phase II, we will incorporate a set of correction coils to transform the Phase I system to a fully functional MRI model magnet. With the cryocooler-SN 2 approach demonstrated in the original project and to be reconfirmed by the Phase I system, the magnet can operate continuously without liquid helium. Significance of the program is further advancement in the following design/operation issues for HTS magnets: 1) using MgB 2, to keep the HTS magnet low-cost; 2) operating at around 10--15 K for enhanced stability; 3) liquid cryogen free "dry'' environment; 4) persistent-mode operation for good temporal stability and ease of operation; 5) protection from quench damages. In addition, the cryogenic approach will allow the system susceptible to power disruptions, expected in many rural communities in the U.S. and underdeveloped nations. We strongly believe that Phase II MRI magnet will become a model of low-cost, easy-to-operate MRI magnets suitable for rural and underdeveloped region. The technologies accumulated in the project will also promote the application of MgB 2 for MRI magnets of even higher field competitive to the current state-of-the-art NbTi magnets, but with substantially lower costs, enhanced stability, and without reliance on liquid helium supply. PUBLIC HEALTH RELEVANCE: The specific aim of this 2-phase renewal project is to complete, at the conclusion of Phase II, a whole-body fully functional MRI magnet that will become a model for low-cost and liquid-helium-free commercial units for small hospitals, rural communities, and underdeveloped nations. These MRI magnets should contribute to early detection and efficient treatment of disease and injury among a large mass of humanity. They would also contribute to reduced health care costs in the U.S.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A high-resolution 1.3-GHz LTS/HTS NMR magnet (1.3G)
A high-resolution 1.3-GHz LTS/HTS NMR magnet (1.3G)
A high-resolution 1.3-GHz LTS/HTS NMR magnet (1.3G)
Administrative Supplement to A high-resolution 1.3-GHz LTS/HTS NMR magnet (1.3G)
国内基金
海外基金
Handbook of the Mathematics of the Arts and Sciences的中文翻译
  • 批准号:
    12226504
  • 项目类别:
    数学天元基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2022
  • 负责人:
    黄朝凌
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    35万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
ARTS在邻苯二甲酸(2-乙基己基)酯诱导的小鼠睾丸间质细胞凋亡中的作用及机理研究
  • 批准号:
    82060278
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    35.0万元
  • 批准年份:
    2020
  • 负责人:
    陈加祥
  • 依托单位:
促进肿瘤凋亡的融合蛋白CPP-TRAIL-ARTS C27的制备及机制研究
  • 批准号:
    81372444
  • 项目类别:
    面上项目
  • 资助金额:
    70.0万元
  • 批准年份:
    2013
  • 负责人:
    易成
  • 依托单位: